| I-67 Huub Jan Kleijn Population Pharmacokinetic Analysis of PD-L1 Checkpoint Inhibitor Cosibelimab in Subjects with Advanced Cancers Wednesday 10:00-11:30 |
| I-67 Huub Jan Kleijn Population Pharmacokinetic Analysis of PD-L1 Checkpoint Inhibitor Cosibelimab in Subjects with Advanced Cancers Wednesday 10:00-11:30 |